Predicting lung attacks in patients with chronic obstructive pulmonary disease

Exacerbations are pivotal events in the progression of chronic obstructive pulmonary disease (COPD) and are associated with significant morbidity and mortality. Early diagnostic biomarkers for exacerbations, enabling early and targeted interventions, are currently lacking. This project aims to explore (bio)markers that are predictive of (preclinical) exacerbation and/or respiratory tract infection.